STOCKS RISE AS DOW EYES GAIN FOR 8TH STRAIGHT SESSION

U.S. consumer sentiment tumbles in May as inflation, interest rate worries take hold

Cumberland Pharmaceuticals Inc. (CPIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

1.6600

-0.0700

(-4.05%)

As of 10:48AM EDT. Market open.

Loading interactive chart...

Simply Wall St.
Cumberland Pharmaceuticals First Quarter 2024 Earnings: US$0.14 loss per share (vs US$0.013 profit in 1Q 2023)
Cumberland Pharmaceuticals ( NASDAQ:CPIX ) First Quarter 2024 Results Key Financial Results Revenue: US$8.50m (down...
Thomson Reuters StreetEvents
Q1 2024 Cumberland Pharmaceuticals Inc Earnings Call
Q1 2024 Cumberland Pharmaceuticals Inc Earnings Call
PR Newswire
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands delivered combined revenues of $8.5 million during the first quarter of 2024. The company ended the quarter with $82 million in total assets, $54 million in total liabilities and $27 million of shareholders' equity.